|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Covidien (COV), a $10.25b provider of healthcare products and formerly part of Tyco. |
|---|---|
| Transferring Party | Aspect Medical Systems, Inc., a leader in brain monitoring technology. |
| Sector | Medical Devices |
| Date | September 28, 2009 |
| Analysis Adds a market leading brain monitoring technology and expands Covidien's presence in the OR. Aspect’s premier product — Bispectral Index™ — became the first clinically proven and commercially available direct measure of the effects of anesthetics and sedatives on the brain. The technology is installed in approximately 74% of U.S. operating rooms. Aspect has OEM agreements with 9 leading manufacturers of patient monitoring systems. Deal value -- $210m on $99m in sales. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |